UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000045682
Receipt number R000052136
Scientific Title Genetic analysis study of clonal hematopoiesis in patients following catheter treatment
Date of disclosure of the study information 2021/10/10
Last modified on 2021/10/06 12:51:37

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Genetic analysis study of clonal hematopoiesis in patients following catheter treatment

Acronym

Genetic analysis study of clonal hematopoiesis in patients following catheter treatment

Scientific Title

Genetic analysis study of clonal hematopoiesis in patients following catheter treatment

Scientific Title:Acronym

Genetic analysis study of clonal hematopoiesis in patients following catheter treatment

Region

Japan


Condition

Condition

Cardiovascular disease

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

To analyze clonal hematopoiesis in patients following catheter treatment

Basic objectives2

Bio-availability

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

all-cause death

Key secondary outcomes

heart failure hospitalization


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients who underwent catheter treatment

Key exclusion criteria

Patient refusal

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Hiroshi
Middle name
Last name Iwata

Organization

Juntendo University

Division name

Department of Cardiovascular Biology and Medicine

Zip code

113-8421

Address

2-1-1 Hongo, Bunkyo-ku, Tokyo, Japan

TEL

0338133111

Email

hiroiwata-circ@juntendo.ac.jp


Public contact

Name of contact person

1st name Takuma
Middle name
Last name Koike

Organization

Juntendo University

Division name

Department of Cardiovascular Biology and Medicine

Zip code

113-8421

Address

2-1-1 Hongo, Bunkyo-ku, Tokyo, Japan

TEL

0338133111

Homepage URL


Email

t-koike@juntendo.ac.jp


Sponsor or person

Institute

Juntendo University

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Juntendo University

Address

2-1-1 Hongo, Bunkyo-ku, Tokyo, Japan

Tel

0338133111

Email

kenkyu5858@juntendo.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

順天堂大学医学部附属順天堂医院(東京都)


Other administrative information

Date of disclosure of the study information

2021 Year 10 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2021 Year 08 Month 16 Day

Date of IRB


Anticipated trial start date

2021 Year 10 Month 10 Day

Last follow-up date

2024 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

single center observational study


Management information

Registered date

2021 Year 10 Month 06 Day

Last modified on

2021 Year 10 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000052136